Results 11 to 20 of about 590,194 (288)
Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt [PDF]
Human Vaccines & Immunotherapeutics, 2019 We described the relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt. Parent-child dyads that were eligible for both meningococcal and HPV vaccines participated in pre-visit surveys and ...
Terresa J. Eun +6 more
doaj +2 more sources
Vaccines against Meningococcal Diseases [PDF]
Microorganisms, 2020 Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening conditions. Thanks to advancements in vaccine development, vaccines are now available for five out of six meningococcal disease-causing serogroups (A, B, C, W,
Mariagrazia Pizza +2 more
doaj +3 more sources
Infectious Diseases and Therapy, 2019 Neisseria meningitidis is a major cause of meningitis and septicemia with cases, outbreaks, and epidemics reported globally in industrialized and non-industrialized countries. N. meningitidis is categorized into 12 serogroups; however, only 5 serogroups (
Jessica Presa +4 more
doaj +2 more sources
Human Vaccines & Immunotherapeutics, 2020 Neisseria meningitidis can lead to invasive meningococcal disease to which young children are particularly vulnerable. We assessed the immunogenicity and safety of Sanofi Pasteur’s investigational quadrivalent (serogroups A, C, Y, and W) meningococcal ...
Timo Vesikari +5 more
doaj +2 more sources
Meningococcal Vaccine Trials [PDF]
, 2003 The evaluation of meningococcal vaccines in humans is a challenging task. Issues of safety, and benefit to the individual patient and to the community may raise difficult ethical problems. The inherent variability of human responses, the rarity of clinical disease, age-dependence in the immune response, and the role of carriers complicates the ...
Paddy Farrington, Elizabeth Miller
openalex +4 more sources
Pediatric Drugs, 2004 Meningococcal disease is one of the most feared and serious infections in the young and its prevention by vaccination is an important goal. The high degree of antigenic variability of the organism makes the meningococcus a challenging target for vaccine prevention. Meningococcal polysaccharide vaccines against serogroup A and C are efficacious and have
Rüggeberg, J, Pollard, A
openaire +6 more sources
Meningococcal vaccines in China [PDF]
Human Vaccines & Immunotherapeutics, 2021 Meningococcal meningitis caused by Neisseria meningitidis is a reportable infectious disease in China, due to the high incidence of meningitis in the era before the availability of vaccines. The disease incidence was markedly reduced after meningococcal vaccination was introduced in the 1980s.
Shanshan Wang +5 more
openaire +4 more sources
Current status and challenges of meningococcal vaccines development in China
Zhongguo gonggong weisheng, 2022 Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj +1 more source
Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children.
New England Journal of Medicine, 2023 BACKGROUND In September 2015, the four-component, protein-based meningococcal serogroup B vaccine (4CMenB; Bexsero) became available for private purchase in Spain. METHODS We conducted a nationwide matched case-control study to assess the effectiveness
J. Castilla +45 more
semanticscholar +1 more source